NuVasive, Inc. (NUVA) Financial Statements (2025 and earlier)

Company Profile

Business Address 7475 LUSK BLVD
SAN DIEGO, CA 92121
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in millions)

6/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments2522461,03021311873
Cash and cash equivalent24924685721311873
Short-term investments3 173   
Restricted cash and investments      4
Receivables249214207212196199
Inventory, net of allowances, customer advances and progress billings339316301312273247
Inventory339316301312273247
Prepaid expense755101717
Other undisclosed current assets182120171419
Total current assets:8658021,562764618559
Noncurrent Assets
Finance lease, right-of-use asset, after accumulated amortization   1
Operating lease, right-of-use asset9510310267
Property, plant and equipment  304286266239215
Intangible assets, net (including goodwill)824876712762813818
Goodwill640633560561561537
Intangible assets, net (excluding goodwill)184243152201252281
Restricted cash and investments111121
Deferred income tax assets684816 
Other noncurrent assets241913153039
Other undisclosed noncurrent assets347  856
Total noncurrent assets:1,3591,3521,1311,1211,0901,080
TOTAL ASSETS:2,2252,1542,6931,8851,7081,639
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:1201161109710675
Settlement liabilities25   
Interest and dividends payable15   
Accounts payable 2016171294
Accrued liabilities706959637042
Other undisclosed accounts payable and accrued liabilities302823222728
Debt4492647601
Estimated litigation liability     18
Business combination, contingent consideration, liability678716819
Other undisclosed current liabilities807672886458
Total current liabilities:716201836207179161
Noncurrent Liabilities
Long-term debt and lease obligation444997878697603583
Long-term debt, excluding current maturities444885766623603583
Finance lease, liability    1
Liabilities, other than long-term debt19516155529196
Deferred tax liabilities, net519
Deferred income tax liabilities1333 
Other liabilities151952528678
Operating lease, liability10411211273
Business combination, contingent consideration, liability64140    
Other undisclosed noncurrent liabilities    14  
Total noncurrent liabilities:6401,158933763694679
Total liabilities:1,3561,3591,769970873840
Temporary equity, including noncontrolling interest   5   
Equity
Equity, attributable to parent, including:869795919915835795
Common stock  00000
Treasury stock, value(683)(678)(669)(588)(572)(566)
Additional paid in capital1,4691,4351,5501,4301,3981,364
Accumulated other comprehensive loss(3)(8)(8)(9)(9)(7)
Retained earnings86464582175
Other undisclosed equity, attributable to parent0     
Equity, attributable to noncontrolling interest      4
Total equity:869795919915835799
TOTAL LIABILITIES AND EQUITY:2,2252,1542,6931,8851,7081,639

Income Statement (P&L) ($ in millions)

6/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues1,2021,1391,0511,1681,1021,030
Revenue, net1,030
Cost of revenue
(Cost of Product and Service Sold)
(337)(322)(322)(312)(311)(269)
Gross profit:865817729856791761
Operating expenses(777)(829)(691)(733)(736)(647)
Operating income (loss):88(12)3812354113
Nonoperating expense(36)(46)(86)(43)(45)(39)
Investment income, nonoperating301210
Other nonoperating expense(21)(25)(17)(6)(8)(2)
Interest and debt expense(0)(0)(0)(0)(38)(38)
Income (loss) from continuing operations before equity method investments, income taxes:52(58)(48)80(29)36
Other undisclosed income from continuing operations before income taxes00003838
Income (loss) from continuing operations before income taxes:52(58)(48)81974
Income tax expense (benefit)(12)(6)10(15)47
Income (loss) from continuing operations:40(64)(37)651281
Income (loss) before gain (loss) on sale of properties:(64)(37)651281
Net income (loss):40(64)(37)651281
Net income attributable to noncontrolling interest      2
Net income (loss) available to common stockholders, diluted:40(64)(37)651283

Comprehensive Income ($ in millions)

6/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net income (loss):40(64)(37)651281
Other comprehensive income (loss)  (0)2(1)(2)4
Comprehensive income (loss):40(64)(35)641185
Comprehensive income, net of tax, attributable to noncontrolling interest      2
Other undisclosed comprehensive income, net of tax, attributable to parent5     
Comprehensive income (loss), net of tax, attributable to parent:45(64)(35)641187

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: